Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non–Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09

Autor: Gautschi, Oliver, Mach, Nicholas, Rothschild, Sacha I., Li, Qiyu, Stahel, Rolf A., Zippelius, Alfred, Cathomas, Richard, Früh, Martin, Betticher, Daniel C., Peters, Solange, Rauch, Daniel, Feilchenfeldt, Jonas, Bubendorf, Lukas, Savic, Spasenija, Jaggi, Rolf, Leibundgut, Elisabeth Oppliger, Largiadèr, Carlo, Brutsche, Martin, Pilop, Christiane, Stalder, Lukas, Pless, Miklos, Ochsenbein, Adrian F.
Zdroj: In Clinical Lung Cancer September 2015 16(5):358-365
Databáze: ScienceDirect
Externí odkaz: